Search Results 101-110 of 17205 for ulcerative colitis

  1. A Study to Evaluate the Safety and Effectiveness of Ustekinumab Induction and Maintenance Therapy in Participants with Moderately to Severely Active Ulcerative Colitis - Mayo Clinic

    ... Ulcerative Colitis. Print details. Share; Facebook · Twitter. Overview; Participation eligibility; Participating Mayo Clinic info; More information. Overview.

  2. A Study to Evaluate the Patterns of Use of Biological Agents and Risk Factors for Discontinuation of Agents in Pediatric Crohn’s Disease (CD) and Ulcerative Colitis (UC) within the Pediatric Population - Mayo Clinic

    ... Ulcerative Colitis (UC) within the Pediatric Population. Print details. Share ... ulcerative colitis (UC) within the ICN network. This will be a ...

  3. A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) - Mayo Clinic

    A Long-Term Registry of Humira® (Adalimumab) in Patients With Moderately to Severely Active Ulcerative Colitis (UC) · More about research at Mayo Clinic · Mayo ...

  4. A Study of the Effectiveness and Safety of Vedolizumab Compared to Adalimumab for Participants with Ulcerative Colitis - Mayo Clinic

    ... ulcerative colitis. Participation eligibility. Participant eligibility ... colitis, radiation colitis, diverticular disease associated with colitis, or ...

  5. A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis - Mayo Clinic

    A Study of the Long-Term Safety and Effectiveness of Adalimumab for Repeat Treatment of Pediatric Patients with Ulcerative Colitis · Overview · Participation ...

  6. Health care maintenance in patients with IBD - Mayo Clinic

    Preventive care is a vital part of the management required for patients with inflammatory bowel disease (IBD), especially for individuals who receive ...

  7. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

    Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) · Share · Facebook · Twitter.

  8. Study for Participants With Ulcerative Colitis Previously Enrolled in Etrolizumab Phase II/III Studies - Mayo Clinic

    ... ulcerative colitis (UC) participants previously enrolled in etrolizumab Phase II/III studies. Participants with moderate to severe UC who were enrolled in ...

  9. Patients with Inflammatory Bowel Disease Have Higher Risk of Melanoma - Mayo Clinic News Network

    More than 1.5 million Americans have Crohn's disease or ulcerative colitis, the most common forms of inflammatory bowel disease. Both conditions inflame the ...

  10. Adverse effects related to Heplisav-B vaccination in patients with Inflammatory Bowel Disease - Mayo Clinic

    ... ulcerative colitis or Crohn's disease. This new vaccine has been found to be more effective than the existing vaccine Engerix in people without ulcerative ...